There is a discrepancy between reported (<5%) and suggested (40-50%) statin-induced myopathy incidence.

“there is information that the statin manufacturers one of the person who you know promote statins actually also promotes a kit to analyze myopathy in patients who are on statins but when that same clinician is talking about clinical data of this benefits of statin he says that myopathies less is present in less than 5% but the same kit that he's selling talks about myopathy being as common as 40 to 50 percent”